The Enterprise Value as of September 2024 (TTM) for Spectrum Pharmaceuticals, Inc. (SPPI) is 186.84M

According to Spectrum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 186.84M. This represents a change of 113.16% compared to the average of 87.65M of the last 4 quarters.

Spectrum Pharmaceuticals, Inc. (SPPI) Historical Enterprise Value (quarterly & annually)

How has SPPI Enterprise Value performed in the past?

The mean historical Enterprise Value of Spectrum Pharmaceuticals, Inc. over the last ten years is 456.00M. The current 186.84M Enterprise Value has changed 4.00% with respect to the historical average. Over the past ten years (40 quarters), SPPI's Enterprise Value was at its highest in in the June 2018 quarter at 2.02B. The Enterprise Value was at its lowest in in the September 2022 quarter at 53.98M.

Spectrum Pharmaceuticals, Inc. (SPPI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Spectrum Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Spectrum Pharmaceuticals, Inc. (SPPI) Average Enterprise Value

How has SPPI Enterprise Value performed in the past?

The current Enterprise Value of Spectrum Pharmaceuticals, Inc. (SPPI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Spectrum Pharmaceuticals, Inc. (SPPI) Enterprise Value vs. Peers

How is SPPI’s Enterprise Value compared to its peers?

Spectrum Pharmaceuticals, Inc.’s Enterprise Value is greater than Selecta Biosciences, Inc. (69.24M), less than Paratek Pharmaceuticals, Inc. (344.90M), less than Corvus Pharmaceuticals, Inc. (237.94M), less than Immutep Limited (412.67M), less than Icosavax, Inc. (713.87M), less than Ardelyx, Inc. (1.38B), greater than Zura Bio Limited (42.42M), greater than Hepion Pharmaceuticals, Inc. (2.24M), greater than AVROBIO, Inc. (-85302404.00), greater than Verastem, Inc. (55.08M), less than Agios Pharmaceuticals, Inc. (2.44B), less than bluebird bio, Inc. (240.30M), less than Intercept Pharmaceuticals, Inc. (915.81M), less than Karyopharm Therapeutics Inc. (201.87M), less than BioLineRx Ltd. (0), greater than Lexicon Pharmaceuticals, Inc. (77.24M), less than Seres Therapeutics, Inc. (652.06M), less than ImmunityBio, Inc. (286.75M), less than Gamida Cell Ltd. (3.22B), greater than Rigel Pharmaceuticals, Inc. (57.65M), less than Geron Corporation (258.64M), less than ImmunoGen, Inc. (2.53B), less than null (8.19B),

Build a custom stock screener for Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spectrum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spectrum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.